HAPASIL SUSPENSION ORAL 150 mg/ml
HAPASIL SUSPENSION ORAL 150 mg/ml
Not authorised
- Netobimin
Product identification
Medicine name:
HAPASIL SUSPENSION ORAL 150 mg/ml
Active substance:
- Netobimin
Target species:
-
Cattle
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Netobimin150.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Cattle
-
Meat and offal12day
-
Milk3day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Spain
Package description:
- Available only in Spanish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Merck Sharp & Dohme Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
- Trirx Segre
Responsible authority:
- Spanish Agency For Medicines And Health Products
Authorisation number:
- 242 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 8/11/2022
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 8/11/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 8/11/2022
How useful was this page?:
